glp-1 coverage medicaid There was a lot of conversation about Medicare and medications last week, and I understand why. For so many people, the biggest barrier to evidence-based treatment has never been lack of GLP-1s prescriptions for weight loss
Description
What Clinical Trials Reveal About Weight Regain After Stopping GLP-1s A recent systematic review and meta-analysis of randomized controlled trials offers a clear picture of weight regain


Open conversations, proactive symptom tracking, and personalized support will help ensure that benefits are sustained while minimizing risks over time.
For example, in clinical trials of semaglutide (Ozempic) for type 2 diabetes, headaches were reported in approximately 4-8% of patients depending on dose

These probiotics have a neutral taste and won't affect the sensory qualities of foods
While these GLP1s were 20 years in the making, looking at the 80+ GLP1s in Phase 2/3 clinical trials, with both their increased efficacy and potential wide ranging utility beyond diabetes and obesity, I can confidently say This is only the beginning of how they will change our world.
